| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 15.618 | 26.374 | 33.930 | 45.095 | 60.350 | 64.610 | 60.944 |
| Total Income - EUR | - | - | - | 15.619 | 26.376 | 33.933 | 45.102 | 60.376 | 64.628 | 61.174 |
| Total Expenses - EUR | - | - | - | 12.091 | 20.513 | 19.545 | 23.594 | 43.459 | 41.363 | 45.791 |
| Gross Profit/Loss - EUR | - | - | - | 3.528 | 5.863 | 14.388 | 21.508 | 16.917 | 23.265 | 15.383 |
| Net Profit/Loss - EUR | - | - | - | 3.372 | 5.600 | 14.195 | 21.208 | 16.325 | 22.715 | 14.692 |
| Employees | - | - | - | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Elekes Davmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 574 | 494 | 2.174 | 1.838 | 2.987 | 3.549 |
| Current Assets | - | - | - | 4.885 | 6.603 | 15.618 | 35.710 | 17.591 | 39.095 | 54.579 |
| Inventories | - | - | - | 929 | 381 | 391 | 1.304 | 568 | 608 | 670 |
| Receivables | - | - | - | 0 | 0 | 2.067 | 3.464 | 0 | 0 | 2.497 |
| Cash | - | - | - | 3.956 | 6.222 | 13.160 | 30.942 | 17.023 | 38.487 | 51.412 |
| Shareholders Funds | - | - | - | 3.522 | 5.755 | 14.348 | 35.238 | 16.475 | 39.141 | 53.614 |
| Social Capital | - | - | - | 150 | 148 | 145 | 142 | 142 | 142 | 141 |
| Debts | - | - | - | 1.363 | 1.421 | 1.763 | 2.646 | 2.953 | 2.941 | 4.514 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Elekes Davmed S.r.l.